Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 3
1981 1
1982 1
1983 3
1984 2
1985 7
1986 1
1987 3
1988 1
1989 2
1990 5
1991 3
1992 5
1993 6
1994 3
1995 2
1996 2
1997 3
1998 1
1999 10
2000 4
2001 5
2002 3
2003 2
2004 5
2005 4
2006 4
2007 8
2008 10
2009 5
2010 4
2011 1
2012 5
2013 7
2014 11
2015 9
2016 10
2017 10
2018 14
2019 11
2020 13
2021 10
2022 9
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
DESIGN: The Treatment of Graves' Orbitopathy to Reduce Proptosis with Teprotumumab Infusions in an Open-Label Clinical Extension Study (OPTIC-X) is a teprotumumab treatment and re-treatment trial following the placebo-controlled teprotumumab Phase 3 Treatment of Graves' Or …
DESIGN: The Treatment of Graves' Orbitopathy to Reduce Proptosis with Teprotumumab Infusions in an Open-Label Clinical Extension Stud …
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial.
Lois N, Campbell C, Waugh N, Azuara-Blanco A, Maredza M, Mistry H, McAuley D, Acharya N, Aslam TM, Bailey C, Chong V, Downey L, Eleftheriadis H, Fatum S, George S, Ghanchi F, Groppe M, Hamilton R, Menon G, Saad A, Sivaprasad S, Shiew M, Steel DH, Talks JS, Doherty P, McDowell C, Clarke M; DIAMONDS Study Group. Lois N, et al. Ophthalmology. 2023 Jan;130(1):14-27. doi: 10.1016/j.ophtha.2022.08.012. Epub 2022 Aug 13. Ophthalmology. 2023. PMID: 35973593 Free article. Clinical Trial.
PURPOSE: To determine clinical effectiveness, safety, and cost-effectiveness of subthreshold micropulse laser (SML), compared with standard laser (SL), for diabetic macular edema (DME) with central retinal thickness (CRT) < 400 mum. ...
PURPOSE: To determine clinical effectiveness, safety, and cost-effectiveness of subthreshold micropulse laser (SML), compared with st …
Research progress on the pathogenesis of diabetic retinopathy.
Li H, Liu X, Zhong H, Fang J, Li X, Shi R, Yu Q. Li H, et al. BMC Ophthalmol. 2023 Sep 11;23(1):372. doi: 10.1186/s12886-023-03118-6. BMC Ophthalmol. 2023. PMID: 37697295 Free PMC article. Review.
This review describes the potential pathogenesis of diabetic retinopathy for experimental studies and clinical practice....
This review describes the potential pathogenesis of diabetic retinopathy for experimental studies and clinical practice....
Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.
Pepple KL, Lin P. Pepple KL, et al. Ophthalmology. 2018 Dec;125(12):1977-1983. doi: 10.1016/j.ophtha.2018.05.014. Epub 2018 Jul 4. Ophthalmology. 2018. PMID: 30458922 Free PMC article. Review.
Therefore, targeting the IL-23/IL-17 axis has become the focus of multiple clinical trials for drug development in patients with autoimmune diseases. We briefly describe the biology of the IL-23/IL-17 axis and its relevance to the pathogenesis of experimental and …
Therefore, targeting the IL-23/IL-17 axis has become the focus of multiple clinical trials for drug development in patients with auto …
Ocular explosions from periocular anesthetic injections: a clinical, histopathologic, experimental, and biophysical study.
Bullock JD, Warwar RE, Green WR. Bullock JD, et al. Ophthalmology. 1999 Dec;106(12):2341-52; discussion 2352-3. doi: 10.1016/S0161-6420(99)90538-9. Ophthalmology. 1999. PMID: 10599669
DESIGNS/PARTICIPANTS: Clinical, histopathologic, experimental animal, autopsy eye, and theoretical biophysical study. ...RESULTS: The findings of anterior and posterior scleral rupture, retinal detachment, vitreous hemorrhage, and lens extrusion were observed cli …
DESIGNS/PARTICIPANTS: Clinical, histopathologic, experimental animal, autopsy eye, and theoretical biophysical study. ...RESUL …
Cuticular Drusen: Clinical Phenotypes and Natural History Defined Using Multimodal Imaging.
Balaratnasingam C, Cherepanoff S, Dolz-Marco R, Killingsworth M, Chen FK, Mendis R, Mrejen S, Too LK, Gal-Or O, Curcio CA, Freund KB, Yannuzzi LA. Balaratnasingam C, et al. Ophthalmology. 2018 Jan;125(1):100-118. doi: 10.1016/j.ophtha.2017.08.033. Epub 2017 Sep 28. Ophthalmology. 2018. PMID: 28964580
PURPOSE: To define the range and life cycles of cuticular drusen phenotypes using multimodal imaging and to review the histologic characteristics of cuticular drusen. DESIGN: Retrospective, observational cohort study and experimental laboratory study. PARTICIPANTS: Two hun …
PURPOSE: To define the range and life cycles of cuticular drusen phenotypes using multimodal imaging and to review the histologic characteri …
Dyslipidemia and Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
Das R, Kerr R, Chakravarthy U, Hogg RE. Das R, et al. Ophthalmology. 2015 Sep;122(9):1820-7. doi: 10.1016/j.ophtha.2015.05.011. Epub 2015 Jul 3. Ophthalmology. 2015. PMID: 26150053 Review.
TOPIC: A systematic review and meta-analysis of dyslipidemia and diabetic macular edema (DME). CLINICAL RELEVANCE: Diabetic macular edema causes impairment of vision in patients with diabetes, and dyslipidemia has been reported as a risk factor for its development. ...
TOPIC: A systematic review and meta-analysis of dyslipidemia and diabetic macular edema (DME). CLINICAL RELEVANCE: Diabetic macular e …
Scleral Buckle, Vitrectomy, or Combined Surgery for Inferior Break Retinal Detachment: Systematic Review and Meta-Analysis.
Bonnar J, Tan CH, McCullough P, Wright DM, Williamson T, Lois N; IRB-RRD Study Group. Bonnar J, et al. Ophthalmol Retina. 2023 Oct;7(10):837-847. doi: 10.1016/j.oret.2023.05.006. Epub 2023 May 13. Ophthalmol Retina. 2023. PMID: 37187441 Free article. Review.
TOPIC: To compare outcomes of scleral buckle (SB), pars plana vitrectomy (PPV), and combined PPV-SB to treat rhegmatogenous retinal detachments (RRDs) with inferior retinal breaks (IRBs). CLINICAL RELEVANCE: Rhegmatogenous retinal detachments with IRBs are not uncommon; th …
TOPIC: To compare outcomes of scleral buckle (SB), pars plana vitrectomy (PPV), and combined PPV-SB to treat rhegmatogenous retinal detachme …
230 results